retatrutide ly3437943 glp-1 gip glucagon triple agonist mechanism Retatrutide is not “just another GLP1.” It Glucagon and retatrutide‐induced ANGPTL3/8 secretion

It is designed as a triple agonist that activates GIP, GLP-1, and glucagon receptors

This suggests that BN may be an effective treatment for obesity and NASH (42)

ABSTRACT KEY FIGURE Highlights The DEVELOPMENT AND USE OF GLUCAGON-LIKE PEPTIDE-1 STRUCTURE, DISTRIBUTION, AND PHYSIOLOGICAL FUNCTION OF GLP-1 GLP-1 MODULATES LIPID METABOLISM CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS GLP-1 AND DUAL AGONISTS CONCLUSIONS NOTES REFERENCES About this article ABSTRACT Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus

HSA/FSA eligible HSA/FSA eligible